Roche shares fall as new drug sales disappoint
By Bhanvi Satija and Ludwig Burger FRANKFURT (Reuters) – Shares in Swiss drugmaker Roche fell on Thursday after sales of its new treatments for eye diseases and hemophilia disappointed the market, even as its nine-month revenue broadly met expectations. Although Roche raised its full-year adjusted profit forecast and has stepped up efforts to enter the…